Sanofi (LON:0O59)

Sanofi Statistics

Total Valuation

Sanofi has a market cap or net worth of GBP 82.91 billion. The enterprise value is 94.17 billion.

Market Cap	82.91B
Enterprise Value	94.17B

Important Dates

The last earnings date was Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	May 12, 2025

Share Statistics

Current Share Class	1.21B
Shares Outstanding	n/a
Shares Change (YoY)	-2.84%
Shares Change (QoQ)	-0.44%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	49.99%
Float	1.09B

Valuation Ratios

The trailing PE ratio is 12.16 and the forward PE ratio is 9.46.

PE Ratio	12.16
Forward PE	9.46
PS Ratio	2.03
PB Ratio	1.33
P/TBV Ratio	24.91
P/FCF Ratio	10.69
P/OCF Ratio	8.84
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.68, with an EV/FCF ratio of 12.14.

EV / Earnings	13.82
EV / Sales	2.33
EV / EBITDA	8.68
EV / EBIT	11.67
EV / FCF	12.14

Financial Position

The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.28.

Current Ratio	1.09
Quick Ratio	0.28
Debt / Equity	0.28
Debt / EBITDA	1.60
Debt / FCF	2.29
Interest Coverage	16.82

Financial Efficiency

Return on equity (ROE) is 6.66% and return on invested capital (ROIC) is 9.17%.

Return on Equity (ROE)	6.66%
Return on Assets (ROA)	4.56%
Return on Invested Capital (ROIC)	9.17%
Return on Capital Employed (ROCE)	9.62%
Weighted Average Cost of Capital (WACC)	5.69%
Revenue Per Employee	491,732
Profits Per Employee	82,240
Employee Count	82,878
Asset Turnover	0.36
Inventory Turnover	0.80

Taxes

In the past 12 months, Sanofi has paid 909.88 million in taxes.

Income Tax	909.88M
Effective Tax Rate	17.33%

Stock Price Statistics

The stock price has decreased by -22.05% in the last 52 weeks. The beta is 0.40, so Sanofi's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-22.05%
50-Day Moving Average	82.55
200-Day Moving Average	84.93
Relative Strength Index (RSI)	43.89
Average Volume (20 Days)	849,982

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sanofi had revenue of GBP 40.75 billion and earned 6.82 billion in profits. Earnings per share was 5.58.

Revenue	40.75B
Gross Profit	29.48B
Operating Income	8.26B
Pretax Income	5.25B
Net Income	6.82B
EBITDA	11.06B
EBIT	8.26B
Earnings Per Share (EPS)	5.58

Balance Sheet

The company has 6.68 billion in cash and 17.73 billion in debt, with a net cash position of -11.05 billion.

Cash & Cash Equivalents	6.68B
Total Debt	17.73B
Net Cash	-11.05B
Net Cash Per Share	n/a
Equity (Book Value)	62.56B
Book Value Per Share	51.35
Working Capital	2.27B

Cash Flow

In the last 12 months, operating cash flow was 9.38 billion and capital expenditures -1.62 billion, giving a free cash flow of 7.76 billion.

Operating Cash Flow	9.38B
Capital Expenditures	-1.62B
Free Cash Flow	7.76B
FCF Per Share	n/a

Margins

Gross margin is 72.34%, with operating and profit margins of 20.27% and 16.72%.

Gross Margin	72.34%
Operating Margin	20.27%
Pretax Margin	12.89%
Profit Margin	16.72%
EBITDA Margin	27.14%
EBIT Margin	20.27%
FCF Margin	19.03%

Dividends & Yields

This stock pays an annual dividend of 3.30, which amounts to a dividend yield of 4.17%.

Dividend Per Share	3.30
Dividend Yield	4.17%
Dividend Growth (YoY)	2.06%
Years of Dividend Growth	2
Payout Ratio	59.08%
Buyback Yield	2.84%
Shareholder Yield	7.01%
Earnings Yield	8.22%
FCF Yield	9.36%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6